Engineering of Arteries in Vitro
Overview
Authors
Affiliations
This review will focus on two elements that are essential for functional arterial regeneration in vitro: the mechanical environment and the bioreactors used for tissue growth. The importance of the mechanical environment to embryological development, vascular functionality, and vascular graft regeneration will be discussed. Bioreactors generate mechanical stimuli to simulate biomechanical environment of arterial system. This system has been used to reconstruct arterial grafts with appropriate mechanical strength for implantation by controlling the chemical and mechanical environments in which the grafts are grown. Bioreactors are powerful tools to study the effect of mechanical stimuli on extracellular matrix architecture and mechanical properties of engineered vessels. Hence, biomimetic systems enable us to optimize chemo-biomechanical culture conditions to regenerate engineered vessels with physiological properties similar to those of native arteries. In addition, this article reviews various bioreactors designed especially to apply axial loading to engineered arteries. This review will also introduce and examine different approaches and techniques that have been used to engineer biologically based vascular grafts, including collagen-based grafts, fibrin-gel grafts, cell sheet engineering, biodegradable polymers, and decellularization of native vessels.
Helms F, Kading D, Aper T, Ruhparwar A, Wilhelmi M Bioengineering (Basel). 2024; 11(11).
PMID: 39593807 PMC: 11591738. DOI: 10.3390/bioengineering11111147.
Luo X, Pang Z, Li J, Anh M, Kim B, Gao G iScience. 2024; 27(11):111215.
PMID: 39555400 PMC: 11565542. DOI: 10.1016/j.isci.2024.111215.
Rodriguez-Soto M, Riveros-Cortes A, Orjuela-Garzon I, Fernandez-Calderon I, Rodriguez C, Vargas N Front Bioeng Biotechnol. 2024; 12:1410863.
PMID: 38903186 PMC: 11188488. DOI: 10.3389/fbioe.2024.1410863.
Harnessing the potential of monocytes/macrophages to regenerate tissue-engineered vascular grafts.
Das A, Smith R, Andreadis S Cardiovasc Res. 2024; 120(8):839-854.
PMID: 38742656 PMC: 11218695. DOI: 10.1093/cvr/cvae106.
Pien N, Di Francesco D, Copes F, Bartolf-Kopp M, Chausse V, Meeremans M Front Bioeng Biotechnol. 2023; 11:1285565.
PMID: 38053846 PMC: 10694796. DOI: 10.3389/fbioe.2023.1285565.